Back to Search
Start Over
FEMALE REPRESENTATION IN CLINICAL TRIALS OF PCSK9 INHIBITORS
- Source :
- Journal of the American College of Cardiology. 73:1749
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- PCSK9-i are gaining traction as effective lipid-lowering agents. We hypothesized that female patients were under-represented in landmark clinical trials of PCSK9-i. In this meta-analysis, we searched and reviewed all currently available randomized clinical trials (RCTs) of PCSK9-i. We defined the
Details
- ISSN :
- 07351097
- Volume :
- 73
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........14a111bc9ba59f5751b157c8ef5fdaff
- Full Text :
- https://doi.org/10.1016/s0735-1097(19)32355-1